Can Your Patient Have a Foley Catheter with Ureteral Stents in Place?
Yes, your patient can have a Foley catheter while ureteral stents are in place, but this combination should be avoided when feasible due to increased infection risk.
Key Recommendation
The most recent guideline evidence indicates that concomitant use of Foley catheters with ureteral stents should be avoided when feasible 1. This recommendation from the 2023 cancer device infection prevention guideline prioritizes reducing infection-related morbidity and mortality. However, there is no absolute contraindication to using both devices simultaneously when clinically necessary.
Clinical Decision Algorithm
When to Use Both Devices:
Acceptable indications for concurrent use:
- Acute urinary retention (postvoid residual >500 mL if asymptomatic, >300 mL if symptomatic) 2
- ICU patients requiring hourly urine output monitoring during active volume resuscitation or vasopressor titration 2
- Specific surgical procedures requiring intraoperative monitoring 2
- Palliative care when aligned with patient comfort goals 2
When to avoid the combination:
- Routine postoperative management without specific indication
- Simple monitoring that doesn't require hourly assessment
- When intermittent catheterization is feasible
Infection Risk Management
Critical Considerations:
The primary concern with using both devices is additive infection risk. Each device independently increases UTI risk:
When both devices are necessary:
Do not screen for or treat asymptomatic bacteriuria - This is a strong recommendation for patients with indwelling catheters 3, 4
Implement strict infection prevention:
Consider prophylactic antibiotics only for high-risk patients with ureteral stents (immunocompromised, recurrent UTIs, uncontrolled diabetes) 1
Duration Considerations
Short-term use (<30 days): More acceptable risk-benefit profile. Recent research shows Foley placement after ureteroscopy with stent placement did not significantly increase complications (5.4% vs 8.9%, all minor) 7.
Long-term use: Strongly discourage concurrent devices. If unavoidable, schedule ureteral stent exchanges every 3 months to prevent encrustation and obstruction 1.
Common Pitfalls to Avoid
Inadvertent ureteral catheterization: Rare but serious complication where Foley is mistakenly placed into ureter instead of bladder, particularly in patients with bladder dysfunction or after chemotherapy 8, 9. Always confirm proper placement before balloon inflation.
Treating asymptomatic bacteriuria: This increases antimicrobial resistance and C. difficile risk without benefit 3
Prolonged unnecessary catheterization: Each additional day increases infection risk exponentially
Practical Management
If both devices are in place:
- Assess daily whether Foley can be removed
- Monitor for symptomatic UTI (fever, hemodynamic instability, new flank pain) - not just positive cultures
- Maintain meticulous pericare 6
- Document specific indication for continued use
Bottom line: The combination is mechanically feasible and sometimes clinically necessary, but minimize duration and avoid routine concurrent use to reduce infection-related morbidity 1.